Should preclinical studies be registered?

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Laine, C. et al. Ann. Intern. Med. 147, 275–277 (2007).

    Article  Google Scholar 

  2. 2

    Anonymous. Nat. Biotechnol. 30, 371 (2012).

  3. 3

    Sena, E.S., van der Worp, H.B., Bath, P.M., Howells, D.W. & Macleod, M. PLoS Biol. 8, e1000344 (2010).

    Article  Google Scholar 

  4. 4

    Kola, I. & Landis, J. Nat. Rev. Drug Discov. 3, 711–715 (2004).

    CAS  Article  Google Scholar 

  5. 5

    Duhem, P.M.M. The Aim and Structure of Physical Theory (Princeton University Press, Princeton, NJ; 1954).

    Google Scholar 

  6. 6

    Bath, P.M. et al. Br. J. Pharmacol. 157, 1157–1171 (2009).

    CAS  Article  Google Scholar 

  7. 7

    Lorente, J.A. & Marshall, J.C. Shock 24, 107–119 (2005).

    CAS  Article  Google Scholar 

  8. 8

    Clarke, J. et al. Regul. Toxicol. Pharmacol. 50, 2–22 (2008).

    CAS  Article  Google Scholar 

  9. 9

    Obach, R.S. et al. J. Pharmacol. Exp. Ther. 283, 46–58 (1997).

    CAS  PubMed  Google Scholar 

  10. 10

    Ross, J.S. et al. Br. Med. J. 344, d7292 (2012).

    Article  Google Scholar 

  11. 11

    Zarin, D.A. et al. J. Am. Med. Assoc. 297, 2112–2120 (2007).

    CAS  Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Jonathan Kimmelman.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kimmelman, J., Anderson, J. Should preclinical studies be registered?. Nat Biotechnol 30, 488–489 (2012).

Download citation

Further reading


Sign up for the Nature Briefing newsletter for a daily update on COVID-19 science.
Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing